The move – if approved by the drug controller general of India (DCGI) – will relax the labelling requirements for weekly oral contraceptive drug, centchroman, and a daily contraceptive drug combination of ethinyloestradiol and levonorgestrel
Simple ethical design
The move – if approved by the drug controller general of India (DCGI) – will relax the labelling requirements for weekly oral contraceptive drug, centchroman, and a daily contraceptive drug combination of ethinyloestradiol and levonorgestrel
